Comparing cauterization and fibrin glue for eye surgery in pterygium treatment
Cauterization Versus fibrin Glue for Conjunctival Autografting in Primary Pterygium Surgery
NA · University of Split, School of Medicine · NCT03321201
This study tests whether using cauterization or fibrin glue during eye surgery helps prevent pterygium from coming back in patients who need the growth removed.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 164 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Split, School of Medicine (other) |
| Locations | 1 site (Split) |
| Trial ID | NCT03321201 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of cauterization versus fibrin glue for conjunctival autografting in patients undergoing primary pterygium surgery. Pterygium is a noncancerous growth that can impair vision and cause discomfort, making surgical removal necessary. The study aims to determine which method reduces the recurrence of pterygium after surgery. Participants will be randomly assigned to receive either cauterization or fibrin glue during their procedure.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with primary nasal pterygia greater than 4 mm that are increasing in size.
Not a fit: Patients with connective tissue diseases, prior eye surgeries, or those using topical anti-glaucoma medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recurrence rates for patients undergoing pterygium surgery.
How similar studies have performed: Other studies have explored various techniques for pterygium surgery, but this specific comparison of cauterization and fibrin glue is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * adults (older than 18 years of age) * both sexes * primary nasal pterygia ˃4 mm, which tends to increase, including patients with reduced visual acuity, chronic inflammation, cosmetic reasons * if the patients had a bilateral pterygium, only one eye will be operated Exclusion criteria: * connective tissue disease * prior eye surgery * chronic use of topical drugs (anti-glaucoma drugs)
Where this trial is running
Split
- University Hospital Split — Split, Croatia (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pterygium of Conjunctiva and Cornea